Skip to main content
  1. Life
  2. Health & Fitness
  3. Healthcare

FDA approves Botox for chronic migraines

See also

On October 15, 2010, the FDA approved Botox injection (onabotulinumtoxinA) to prevent headaches in adults with chronic migraine. Chronic migraine is defined as having a history of migraine headaches and experiencing a headache on 15 or more days in a month.

Botox (onabotulinumtoxinA) used to treat chronic migraine is given every 12 weeks as multiple injections around the head and neck. Allergan Inc., the manufacturer of Botox, says that the treatment is administered by a physician or other qualified medical professional in a series of 31 injections in seven specific sites in the head and neck. This treatment is meant to dull future headache symptoms.

The most common side effects of Botox injections are neck pain and headache. Also, the FDA has placed a “boxed warning” on Botox injection which says the effects of the botulinum toxin may spread from the injection site to other areas of the body causing symptoms similar to botulism. These symptoms may include difficulty swallowing and difficulty breathing which can be life-threatening.

The FDA has not had any reports of serious toxin spread in any of the approved uses for Botox injection.




  • Tom Petty
    Seven overlooked videos that prove the genius of Tom Petty and the Heartbreakers
    Today's Buzz
  • Gaylord Pickens
    Discover Gaylord-Pickens Oklahoma Heritage Museum dollar days
    6 Photos
  • Yoga poses
    Learn how to strengthen your core muscles with these yoga poses
    5 Photos
  • Baby boomer STD rates
    Sexually transmitted diseases: Baby boomers booming STD rates
    7 Photos
  • Open relationships
    Are you thinking about exercising your option to be in an open relationship?
    5 Photos
  • Medical symptoms
    See which symptoms should cause you to seek a doctor’s attention right away
    6 Photos